| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-20156-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50423-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-08997-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-27126-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81041-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52708-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52646-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35227-10ug | |||
| Carrier-Free | NBP2-35227-1mg | |||
| Carrier-Free | NBP2-35227-500ug | |||
![Immunocytochemistry/Immunofluorescence: NKG2D/CD314 Antibody (6E5A7) - Chimeric - Azide and BSA Free [NBP3-20156] - Immunofluorescence analysis of paraformaldehyde fixed human peripheral blood leukocytes stained with the chimeric rabbit IgG version of 6E5A7 (NBP3-20156) (1:1000 dilution) for 1h followed by Alexa Fluor(R) 488 secondary antibody (1:1500 dilution), showing nuclear staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-20156, DAPI, merged channels and an isotype control. The isotype control was anti-fluorescein antibody (NBP2-52638) followed by staining with Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/nbp3-20156_rabbit-nkg2d-cd314-mab-6e5a7-chimeric-azide-bsa-free-2742023924240.png "Immunocytochemistry/Immunofluorescence: NKG2D/CD314 Antibody (6E5A7) - Chimeric - Azide and BSA Free [NBP3-20156] - Immunofluorescence analysis of paraformaldehyde fixed human peripheral blood leukocytes stained with the chimeric rabbit IgG version of 6E5A7 (NBP3-20156) (1:1000 dilution) for 1h followed by Alexa Fluor(R) 488 secondary antibody (1:1500 dilution), showing nuclear staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-20156, DAPI, merged channels and an isotype control. The isotype control was anti-fluorescein antibody (NBP2-52638) followed by staining with Alexa Fluor(R) 488 secondary antibody.")
![Western Blot: NKG2D/CD314 Antibody (6E5A7) - Chimeric - Azide and BSA Free [NBP3-20156] - K562(A) (2ug/ml) and human peripheral blood monocytes(B) (2ug/ml) cells lysate (35ug protein in RIPA buffer) were resolved on a SDS PAGE gel and blots were probed with the chimeric rabbit version of 6E5A7 (NBP3-20156) before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence.](http://images.novusbio.com/fullsize/nbp3-20156_rabbit-nkg2d-cd314-mab-6e5a7-chimeric-azide-bsa-free-2742023924251.png)
![Immunocytochemistry/Immunofluorescence: Fc gamma RII/CD32 Antibody (AT130-5) - Chimeric [NBP3-08997] - Immunofluorescence analysis of paraformaldehyde fixed mouse (Mus musculus) splenocytes on Shi-fix(TM) coverslips, permeabilized with 0.15% Triton stained with the chimeric rabbit version of AT130-5 (NBP3-08997) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (1 ug/ml), showing membrane staining in a subset of cells. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-08997, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/Fc-gamma-RII-CD32-Antibody-AT130-5-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-08997-img0001.jpg "Immunocytochemistry/Immunofluorescence: Fc gamma RII/CD32 Antibody (AT130-5) - Chimeric [NBP3-08997] - Immunofluorescence analysis of paraformaldehyde fixed mouse (Mus musculus) splenocytes on Shi-fix(TM) coverslips, permeabilized with 0.15% Triton stained with the chimeric rabbit version of AT130-5 (NBP3-08997) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (1 ug/ml), showing membrane staining in a subset of cells. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-08997, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor(R) 488 secondary antibody.")
![Western Blot: BAFFR/TNFRSF13C Antibody (5A9B10) [NBP3-27126] - Analysis using BAFFR/TNFRSF13C mAb against HEK293 (1) and BAFFR/TNFRSF13C (AA: extra 1-78)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/nbp3-27126_mouse-baffr-tnfrsf13c-mab-5a9b10-bsa-free-1042024917029.jpg%3Fv=1666702823 "Western Blot: BAFFR/TNFRSF13C Antibody (5A9B10) [NBP3-27126] - Analysis using BAFFR/TNFRSF13C mAb against HEK293 (1) and BAFFR/TNFRSF13C (AA: extra 1-78)-hIgGFc transfected HEK293 (2) cell lysate.")
![Western Blot: BAFFR/TNFRSF13C Antibody (5A9B10) [NBP3-27126] - Analysis using BAFFR/TNFRSF13C mAb against human BAFFR/TNFRSF13C (AA: extra 1-78) recombinant protein. (Expected MW is 34 kDa)](http://images.novusbio.com/fullsize/nbp3-27126_mouse-baffr-tnfrsf13c-mab-5a9b10-bsa-free-10420249181944.jpg%3Fv=1666702823)
![ELISA: BAFFR/TNFRSF13C Antibody (5A9B10) [NBP3-27126] - Black line: Control Antigen (100 ng); Purple line: Antigen (10 ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng)](http://images.novusbio.com/fullsize/nbp3-27126_mouse-baffr-tnfrsf13c-mab-5a9b10-bsa-free-1042024920234.jpg%3Fv=1666702823)
![Flow Cytometry: BAFFR/TNFRSF13C Antibody (5A9B10) [NBP3-27126] - Analysis of Raji cells using BAFFR/TNFRSF13C mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/nbp3-27126_mouse-baffr-tnfrsf13c-mab-5a9b10-bsa-free-10420249181918.jpg%3Fv=1666702823)
![Western Blot: CD2 Antibody (YTH 655) - Chimeric [NBP2-81041] - Western Blot using anti-CD2 antibody (YTH 655) [NBP2-81041]. Human tonsil lysate samples (35ug protein in RIPA buffer) were resolved on a 10% SDS PAGE gel and blots probed with the chimeric rabbit version of YTH 655 [NBP2-81041] at 1 ug/ml before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence. The expected running size for unmodified CD2 is 39.5kDa, but this protein is glycosylated at several residues. NBP2-81041 successfully detected CD2 in human tonsil lysate.](http://images.novusbio.com/fullsize/CD2-Antibody-YTH-655-Chimeric-Western-Blot-NBP2-81041-img0001.jpg "Western Blot: CD2 Antibody (YTH 655) - Chimeric [NBP2-81041] - Western Blot using anti-CD2 antibody (YTH 655) [NBP2-81041]. Human tonsil lysate samples (35ug protein in RIPA buffer) were resolved on a 10% SDS PAGE gel and blots probed with the chimeric rabbit version of YTH 655 [NBP2-81041] at 1 ug/ml before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence. The expected running size for unmodified CD2 is 39.5kDa, but this protein is glycosylated at several residues. NBP2-81041 successfully detected CD2 in human tonsil lysate.")
![Immunocytochemistry/Immunofluorescence: CD2 Antibody (YTH 655) - Chimeric [NBP2-81041] - Immunofluorescence staining of fixed Molt4 cells with anti-CD2 antibody YTH 655 [NBP2-81041]. Immunofluorescence analysis of paraformaldehyde fixed Molt4 cells on Shi-fix coverslips, permeabilized with 0.15% Triton and stained with the chimeric rabbit IgG version of YTH 655 [NBP2-81041] at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1 ug/ml), showing membrane, and some cytoplasmic staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-81041, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/CD2-Antibody-YTH-655-Chimeric-Immunocytochemistry-Immunofluorescence-NBP2-81041-img0002.jpg)
![Western Blot: HLA A2 Antibody (BB7.2) - Chimeric - BSA Free [NBP3-43553] - Daudi cells lysate (35ug protein in RIPA buffer) was resolved via SDS-PAGE, and the subsequent blot was probed with NBP3-43553 at 0.3ug/ml before detection using an appropriate secondary antibody. A primary incubation of 1 hour was used, and proteins were detected by chemiluminescence.](http://images.novusbio.com/fullsize/nbp3-43553_rabbit-hla-a2-mab-bb7-2-chimeric-azide-and-bsa-free-74202522141226.png "Western Blot: HLA A2 Antibody (BB7.2) - Chimeric - BSA Free [NBP3-43553] - Daudi cells lysate (35ug protein in RIPA buffer) was resolved via SDS-PAGE, and the subsequent blot was probed with NBP3-43553 at 0.3ug/ml before detection using an appropriate secondary antibody. A primary incubation of 1 hour was used, and proteins were detected by chemiluminescence.")
![Immunocytochemistry /Immunofluorescence: HLA A2 Antibody (BB7.2) - Chimeric - BSA Free [NBP3-43553] - Immunofluorescence analysis of paraformaldehyde fixed Daudi cells on Shi-fix coverslips stained with NBP3-43553 (1:100 dilution) for 1h followed by Alexa Fluor 488 secondary antibody (1:1000 dilution), showing membrane and cytoplasmic staining. The nuclear stain is DAPI (blue). Panels show, from left-right, top-bottom, NBP3-43553, DAPI, merged channels, and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/nbp3-43553_rabbit-hla-a2-mab-bb7-2-chimeric-azide-and-bsa-free-74202522113040.png)
![Immunocytochemistry/Immunofluorescence: p38 alpha Antibody (M548) [NBP3-23234] - Immunocytochemical labeling of p38 alpha in aldehyde fixed and NP-40 permeabilized human NCI-H446 lung carcinoma cells. The cells were labeled with mouse monoclonal anti-p38 alpha (NBP3-23234). The antibody was detected using goat anti-mouse DyLight(R) 594.](http://images.novusbio.com/fullsize/nbp3-23234_mouse-p38-alpha-mab-m548-199202318202923.jpg "Immunocytochemistry/Immunofluorescence: p38 alpha Antibody (M548) [NBP3-23234] - Immunocytochemical labeling of p38 alpha in aldehyde fixed and NP-40 permeabilized human NCI-H446 lung carcinoma cells. The cells were labeled with mouse monoclonal anti-p38 alpha (NBP3-23234). The antibody was detected using goat anti-mouse DyLight(R) 594.")
![Western Blot: p38 alpha Antibody (M548) [NBP3-23234] - Western blot analysis of human A431 cells (lanes 1 & 2) and rat A7r5 cells (lanes 3 & 4). The blot was probed with mouse monoclonal anti-p38 alpha (C-terminal) clone M548 at a dilution of 1:250 (lanes 1 & 3) or 1:1000 (lanes 2 & 4).](http://images.novusbio.com/fullsize/nbp3-23234_mouse-p38-alpha-mab-m548-19920231856916.jpg)
![Immunocytochemistry/Immunofluorescence: p38 alpha Antibody (M138) [NBP3-23233] - Immunocytochemical labeling of activated p38 MAPK in pervanadate-treated mouse C2C12. The cells were labeled with mouse monoclonal p38 alpha MAPK and p38 MAPK (T180/Y182) antibodies, then the antibodies were detected using appropriate secondary antibodies conjugated to Cy3.](http://images.novusbio.com/fullsize/nbp3-23233_mouse-p38-alpha-mab-m138-19920231410114.jpg "Immunocytochemistry/Immunofluorescence: p38 alpha Antibody (M138) [NBP3-23233] - Immunocytochemical labeling of activated p38 MAPK in pervanadate-treated mouse C2C12. The cells were labeled with mouse monoclonal p38 alpha MAPK and p38 MAPK (T180/Y182) antibodies, then the antibodies were detected using appropriate secondary antibodies conjugated to Cy3.")
![Western Blot: p38 alpha Antibody (M138) [NBP3-23233] - Western blot analysis of A431 cells serum starved overnight (lanes 1 & 3) or treated with pervanadate (1 mM) for 30 minutes (lanes 2 & 4). The blot was probed with anti-p38 alpha (lanes 1 & 2) or anti-p38 (T180/Y182) (lanes 3-4). Lanes 5-7 shows a blot of A431 cells treated with pervanadate and probed with anti-p38 (T180/Y182) in the presence of no peptide (lane 5), phospho-ERK1 (T202/Y204) peptide (lane 6) or phospho-p38 (T180/Y182) peptide (lane 7).](http://images.novusbio.com/fullsize/nbp3-23233_mouse-p38-alpha-mab-m138-19920231252360.jpg)
![Immunocytochemistry/Immunofluorescence: CD46 Antibody (M037) [NBP3-23191] - Immunocytochemical labeling of CD46 in aldehyde fixed human NCIH1915 lung carcinoma cells. The cells were labeled with mouse monoclonal anti-CD46 (NBP3-23191). The antibody was detected using goat anti-mouse Ig:DyLight(R) 594.](http://images.novusbio.com/fullsize/nbp3-23191_mouse-cd46-mab-m037-19920231759445.jpg "Immunocytochemistry/Immunofluorescence: CD46 Antibody (M037) [NBP3-23191] - Immunocytochemical labeling of CD46 in aldehyde fixed human NCIH1915 lung carcinoma cells. The cells were labeled with mouse monoclonal anti-CD46 (NBP3-23191). The antibody was detected using goat anti-mouse Ig:DyLight(R) 594.")
![Immunocytochemistry/Immunofluorescence: CD46 Antibody (M037) [NBP3-23191] - Immunocytochemical labeling of CD46 in aldehyde fixed human NCIH1915 lung carcinoma cells. The cells were labeled with mouse monoclonal anti-CD46 (NBP3-23191). The antibody was detected using goat anti-mouse Ig:DyLight(R) 594.](http://images.novusbio.com/fullsize/nbp3-23191_mouse-cd46-mab-m037-19920231240371.jpg)
![Western Blot: CD46 Antibody (M037) [NBP3-23191] - Western blot of native lysates from NCI-H2052 mesothelial cells (lane 1), SK-MES-1 squamous carcinoma (lane 2), MDA-MB-231 breast carcinoma (lane 3), MeWo melanoma (lane 4), A431 skin adenocarcinoma (lane 5), LNCaP prostate cancer cells (lane 6), and MCF7 breast cancer cells (lane 7). The blot was probed with mouse monoclonal anti-CD46 (NBP3-23191) at 1:1000.](http://images.novusbio.com/fullsize/nbp3-23191_mouse-cd46-mab-m037-19920231240375.jpg)
![Flow Cytometry: Integrin beta 1/CD29 Antibody (K20) [NBP2-52708] - Flow-cytometry using anti-CD29 antibody K20 (NBP2-52708) Human leukocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of K20 (panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/Integrin-beta-1-CD29-Antibody-K20-NBP2-52708-img0001.jpg "Flow Cytometry: Integrin beta 1/CD29 Antibody (K20) [NBP2-52708] - Flow-cytometry using anti-CD29 antibody K20 (NBP2-52708) Human leukocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of K20 (panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Flow Cytometry: CD20 Antibody (10F381 (rituximab)) - Chimeric [NBP2-52646] - Flow-cytometry using the anti-CD20 research biosimilar antibody Rituximab. Cynomolgus monkey lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Rituximab (NBP2-52646, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD20-Antibody-10F381-rituximab-Chimeric-Flow-Cytometry-NBP2-52646-img0003.jpg "Flow Cytometry: CD20 Antibody (10F381 (rituximab)) - Chimeric [NBP2-52646] - Flow-cytometry using the anti-CD20 research biosimilar antibody Rituximab. Cynomolgus monkey lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Rituximab (NBP2-52646, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Flow Cytometry: CD20 Antibody (10F381 (rituximab)) - Chimeric [NBP2-52646] - Flow-cytometry using the anti-CD20 research biosimilar antibody Rituximab. Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Rituximab (NBP2-52646, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD20-Antibody-10F381-rituximab-Chimeric-Flow-Cytometry-NBP2-52646-img0001.jpg)
![Flow Cytometry: CD20 Antibody (10F381 (rituximab)) - Chimeric [NBP2-52646] - Flow-cytometry using the anti-CD20 research biosimilar antibody Rituximab. Rhesus monkey lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Rituximab (NBP2-52646, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD20-Antibody-10F381-rituximab-Chimeric-Flow-Cytometry-NBP2-52646-img0002.jpg)
![SDS-Page: Rat IL-1 alpha/IL-1F1 Protein [NBP2-35227]](http://images.novusbio.com/fullsize/Rat-IL-1-alpha-IL-1F1-Protein-SDS-Page-NBP2-35227-img0001.jpg "SDS-Page: Rat IL-1 alpha/IL-1F1 Protein [NBP2-35227]")